Charts of the Day: Incyte, WD-40, Gain Capital Holdings

Yahoo Finance Video

Incyte's experimental melanoma treatment fails to meet its phase 3 primary endpoint; WD-40 beat on earnings, missed on revenue and sales growth; Gain Capital Holdings to continue rollout of its cryptocurrency offerings

Scroll to continue with content

What to Read Next